Stockreport

Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a) [Yahoo! Finance]

Silence Therapeutics Plc - American Depository Share  (SLN) 
PDF LONDON, April 08, 2024 BUSINESS WIRE )--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), an experienced and innovative biotechnology company committe [Read more]